REGN EPS Estimates
Regeneron Pharmaceuticals, Inc.
$930.67
-$42.69(-4.39%)
79
Overall
80
Value
100
Tech
57
Quality
Market Cap
$100.69B
Volume
1.39M
52W Range
$591.52 - $935.35
Target Price
$873.03
REGN EPS estimates: the consensus estimate for Regeneron Pharmaceuticals, Inc.'s current fiscal year is $68.68 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
REGN EPS Estimates
- EPS estimate, current quarter
- $17.55
- EPS estimate, next quarter
- $10.66
- EPS estimate, current year
- $68.68
- EPS estimate, next year
- $70.61
- EPS growth, 3-year
- +2.06%
| Fiscal year | EPS |
|---|---|
| 2025 | $43.07 |
| 2024 | $40.90 |
| 2023 | $37.05 |
| 2022 | $40.51 |
| 2021 | $76.40 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | REGN | $930.67 | -4.4% | 1.39M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Regeneron Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW